Exosome mimetics: a novel class of drug delivery systems. by Kooijmans, SA, Vader, P, van Dommelen, S, van Solinge, W, Schiffelers, R

Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery by Van Dommelen, S, Vader, P, Lakhal, S, Kooijmans, S, Van Solinge, W, Wood, M, Schiffelers, R

Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. by van Dommelen, S, Vader, P, Lakhal, S, Kooijmans, SA, van Solinge, W, Wood, M, Schiffelers, R

Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency. by van Wijk, R, van Solinge, W, Nerlov, C, Beutler, E, Gelbart, T, Rijksen, G, Nielsen, F

Highly efficient depletion strategy for the two most abundant erythrocyte soluble proteins improves proteome coverage dramatically. by Ringrose, J, van Solinge, W, Mohammed, S, O'Flaherty, M, van Wijk, R, Heck, A, Slijper, M

Taxol(®)-induced phosphatidylserine exposure and microvesicle formation in red blood cells is mediated by its vehicle Cremophor(®) EL. by Vader, P, Fens, M, Sachini, N, van Oirschot, B, Andringa, G, Egberts, A, Gaillard, C, Rasmussen, J, van Wijk, R, van Solinge, W, Schiffelers, R

PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE... by VAN DIJK M., RAB M., VAN OIRSCHOT B., BOS J., DERICHS C., RIJNEVELD A., CNOSSEN M., NUR E., BIEMOND B., BARTELS M., JANS J., VAN SOLINGE W., SCHUTGENS R., VAN WIJK R., VAN BEERS E.

Get full text